Randomised controlled trial to evaluate efficasy of vatsnabhadi lepa in comparison with eusol in dushta vrana
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- Treatment will continue till signs of shudhavrana are seen 3 weeks
研究概览
简要总结
Infected wound is one of the major contributor to morbidity and mortality
World wise annually 2 million cases concern annually worldwide. Each year it is
to estimated that infected wound developed in 2%-5% of the 16 million
patients undergoing surgical procedure. In developing countries where
resources are scarce is problem is aggravated. In Vatsnabhadi lepa indivisually
all drug has been tested for their different properties but no previous study
has done for this formulation. This study plan to access the efficacy of
vatsnabhadi lepa in management of dushta vrana.
Among all the Mahavisha, Vatsanabha has its own importance. It is the only
Mahavisha that is still recognised and available. Compounds containing
Vatsanabha are enlisted as essential medications for Ayurveda dispensaries
operated under centrally supported programmes of the government of India
研究设计
- 研究类型
- Interventional
- 分配方式
- Coin toss, Lottery, toss of dice, shuffling cards etc
- 盲法
- Open Label
入排标准
- 年龄范围
- 18.00 Year(s) 至 60.00 Year(s)（—）
- 性别
- All
入选标准
- •Patient having infected wound.
- •Wound size 1 × 1 cm to 8 × 8cm.
- •Infected wound due to trauma & accident with foul smell and pus discharge.
- •Post- operative all infected wound.
- •Diabetic Mellitus.
排除标准
- •Gangrenous wound.
- •Neo-plastic ulcer.
- •Burn, Arterial ulcer, Gout, Renal failure.
- •Liver failure.
- •Varicose ulcer.
- •HIV & Immuno-compromised patients.
结局指标
主要结局
Treatment will continue till signs of shudhavrana are seen 3 weeks
时间窗: Treatment will continue till signs of shudhavrana are seen | 3 weeks
次要结局
- To observe the duration required for achieving Shuddha Avastha(To see the adverse effect of vatsnabhadi lepa dressing during the treatment)